Fig. 5From: A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic controlCorrelation between glycated haemoglobin (Hb)A1c and either maximum platelet aggregation response to collagen 2 µg/mL (left) or fibrin clot lysis time (right) at baseline (BL, top) and during treatment with aspirin 75 mg once daily (75, middle) or 300 mg once daily (300, bottom) in patients with type 1 diabetes. Solid blue line represents line of regression and shaded area represents 95% CIBack to article page